R&D News | pharmaphorum

News

UK's Claret Capital raises €575m for European biotechs

London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."

News

Novo Nordisk's IL-6 drug flunks two more heart trials

Novo Nordisk has opted to discontinue two late-stage trials of IL-6 inhibitor ziltivekimab in heart failure, after taking an interim look at the data.

News

Novartis hit as Lp(a) drug fails cardio outcomes trial

Novartis shares have slipped after it revealed its Lp(a)-targeted drug, pelacarsen, failed to reduce cardiovascular risks in a major phase 3 trial.

News

Person holds hand of elderly lady; grey colour scheme

Major trial of Roche Alzheimer's drug kicks off in Europe

The PrevenTRON trial of Roche's Brainshuttle drug trontinemab in preclinical Alzheimer's disease has gotten underway in the UK.

News

Pig to human kidney transplantation hits a new milestone

A pig kidney transplanted into a human patient has broken records by lasting for nine months, buying time until a human donor organ became available.

News

AbbVie's cancer TCE etentamig hits the mark in myeloma

AbbVie has reported positive results with CD3xBCMA bispecific etentamig in multiple myeloma, but can it break into a crowded market?

UK's Claret Capital raises €575m for European biotechs

Novo Nordisk's IL-6 drug flunks two more heart trials

Novartis hit as Lp(a) drug fails cardio outcomes trial

Major trial of Roche Alzheimer's drug kicks off in Europe

Pig to human kidney transplantation hits a new milestone

AbbVie's cancer TCE etentamig hits the mark in myeloma

ESMO26: Moderna, MSD reveal cancer jab data early after leak

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks